Company news

ADMA Biologics Inc news in 2020

ADMA Biologics Inc's news releases, calls and decks from 2020, newest first.

View company

ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors

December 8, 2020

ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Maryville, TN

November 30, 2020

ADMA Biologics to Participate in Jefferies 2020 Virtual London Healthcare Conference

November 9, 2020

ADMA Biologics Reports Third Quarter 2020 Financial Results and Business Highlights

November 4, 2020

ADMA Biologics to Report Third Quarter 2020 Financial Results and Business Highlights on November 5, 2020

October 28, 2020

ADMA Biologics Announces Presentation on Respiratory Viral Infections and New Data on S. Pneumoniae at IDWeek 2020

October 20, 2020

ADMA Biologics to Participate in Morgan Stanley Virtual Healthcare Conference

September 8, 2020

ADMA Biologics Highlights Launch of COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay to Detect SARS-CoV-2 Neutralizing Antibodies in Plasma

September 2, 2020

ADMA Biologics to Participate in Upcoming Investor Conferences

September 1, 2020

ADMA Biologics Reports Business Highlights and Second Quarter 2020 Financial Results

August 4, 2020

ADMA Biologics to Report Business Highlights and Second Quarter 2020 Financial Results on August 5, 2020

July 28, 2020

ADMA Biologics Opens Its Newest ADMA BioCenters Plasma Collection Facility

July 5, 2020

ADMA Biologics Announces Martha J. Demski Elected to Board of Directors

June 22, 2020

ADMA Biologics to Participate in Jefferies Virtual Healthcare Conference

May 26, 2020

ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients

May 20, 2020

ADMA Biologics Provides Corporate Update on Supply Chain Robustness and Recent Accomplishments

May 6, 2020

ADMA Biologics Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress

May 5, 2020

ADMA Biologics to Report First Quarter 2020 Financial Results on May 6, 2020

April 28, 2020

ADMA Biologics Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Company Progress

March 11, 2020

ADMA Biologics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020

March 4, 2020

ADMA Biologics Highlights Expanded Intellectual Property Portfolio for Specialty Plasma Derived Immune Globulins Targeted Against Respiratory Infections

March 2, 2020

ADMA Biologics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection with Its Public Offering of Common Stock

February 23, 2020

ADMA Biologics Receives BioNJ 2020 Innovator Award for ASCENIV™

February 10, 2020

ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock

February 5, 2020

ADMA Biologics Announces Pricing of Upsized $82.3 Million Public Offering of Common Stock

February 5, 2020

ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2019 Revenues and Provides 2020 Strategic Outlook

January 8, 2020

ADMA Biologics Enters Into a Manufacturing and Supply Agreement to Produce and Sell Plasma-Derived Intermediate Fractions

January 6, 2020

Calls in 2020

Decks in 2020